Neill J C, Bendotti C, Samanin R
Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.
Eur J Pharmacol. 1990 Nov 6;190(1-2):105-12. doi: 10.1016/0014-2999(90)94117-g.
d-Fenfluranine has previously been shown to reduce food-rewarded runway behaviour in the rat, an effect thought to be mediated through activation of central 5-HT pathways. We now examined in more detail the mechanism by which d-fenfluramine reduces runway performance and food intake in the 15-trial runway test. The non-selective 5-HT receptor antagonist, metergoline (1.0 mg/kg), significantly antagonised the effect of d-fenfluramine (2.5 mg/kg) in the runway test. In contrast, neither ritanserin, the potent 5-HT2 and 5-HT1C receptor antagonist (0.5 mg/kg), nor the peripheral 5-HT receptor antagonist, xylamidine (3.0 mg/kg), attenuated the effect of d-fenfluramine in this test situation. Metergoline, but not ritanserin or xylamidine significantly increased runway performance when administered alone. These data indicate that d-fenfluramine reduces runway performance and food intake through activation of 5-HT1 receptors. In addition, blockade of 5-HT1 receptors can attenuate the development of satiation normally observed under control conditions in the runway test.
右旋芬氟拉明先前已被证明可减少大鼠食物奖励性跑道行为,这种作用被认为是通过激活中枢5-羟色胺(5-HT)途径介导的。我们现在更详细地研究了右旋芬氟拉明在15次试验跑道测试中降低跑道表现和食物摄入量的机制。非选择性5-HT受体拮抗剂美替拉酮(1.0毫克/千克)在跑道测试中显著拮抗了右旋芬氟拉明(2.5毫克/千克)的作用。相比之下,强效5-HT2和5-HT1C受体拮抗剂利坦色林(0.5毫克/千克)以及外周5-HT受体拮抗剂赛拉米定(3.0毫克/千克)在这种测试情况下均未减弱右旋芬氟拉明的作用。单独给药时,美替拉酮而非利坦色林或赛拉米定显著提高了跑道表现。这些数据表明,右旋芬氟拉明通过激活5-HT1受体降低跑道表现和食物摄入量。此外,阻断5-HT1受体可减弱在跑道测试对照条件下通常观察到的饱腹感的发展。